When Do You Start Feeling Wegovy Working — and What Happens First

What the trial data shows about the first weeks on Wegovy

The STEP 1 trial is the most detailed window we have into how semaglutide 2.4mg works over time, and its findings are instructive. Weight loss was not linear. Participants lost relatively little in the first four weeks, with the curve steepening through weeks 12 to 28 and continuing more gradually after that. This mirrors what the NHS medicines information for semaglutide explains about how the drug works: appetite reduction and slower stomach emptying begin early, but the physiological changes that produce measurable fat loss take longer to accumulate.

At the 0.25mg starting dose, semaglutide's job is adjustment, not treatment. The body is learning to tolerate the medicine. Some people feel noticeably less hungry from day three or four; others notice nothing particular until their second or third week. Both are within the normal range. What the evidence tells us consistently is that appetite effects precede weight changes, so the scales are a lagging indicator, not the first sign that anything is happening.

By the time someone reaches the 1.7mg or 2.4mg maintenance dose, the appetite suppression is typically more pronounced and more sustained. The STEP 1 data showed the greatest rate of weight loss occurring between roughly weeks 16 and 36. Patience in the early phase is not passive waiting, it is the mechanism working as designed.

The physical sensations most people describe at each stage

In the first one to two weeks, the most commonly reported experience is a changed relationship with portion size. Food that would previously feel like a normal amount starts to feel like enough sooner. Some people describe a slight heaviness or fullness that lingers longer after eating. These sensations correlate with semaglutide's action on gastric emptying: food moves through the stomach more slowly, so satiety signals arrive earlier.

Nausea is the other early companion for many people, and it is worth understanding its pattern. It tends to arrive in the first few days of a new dose step, often peaking around days three to five, then easing by the end of week two. It is rarely severe at the 0.25mg or 0.5mg stages for most people, but it can be more noticeable when moving to higher doses. Eating smaller meals, avoiding rich or fatty foods during the adjustment period, and staying well hydrated all help, your prescriber or the Patient Information Leaflet will give you specific guidance.

Some people also notice mild fatigue or headache in the early weeks. A small number report feeling warmer than usual; if that is something you are experiencing, there is a dedicated explanation of why Wegovy can cause a sensation of warmth and when it is worth mentioning to your prescriber. Less commonly, people report feeling cooler, which is covered separately in guidance on cold sensations on Wegovy.

When to expect Wegovy to feel different, and when to ask for support

The question our prescribers hear often is: how do I know it is actually working? The honest answer is that appetite change is the primary early signal, and it can be subtle. A useful self-check is whether you are finishing meals you would previously have cleared easily, or whether the urge to snack between meals has reduced. Those are the early signs. If neither is present by week four on the starting dose, it is worth raising at your next clinical review rather than drawing conclusions yourself.

If you are already established on treatment elsewhere and are exploring your options, you can read more about how Wegovy's effects develop over the first months for a fuller picture of the longer timeline. The question of when to start Wegovy itself is also something our clinical team can walk through with you, particularly around timing relative to other medicines or lifestyle changes.

Wegovy is a prescription-only medicine. The side-effect profile (nausea, diarrhoea, constipation, indigestion) is manageable for most people, but some symptoms warrant prompt medical attention. Severe, persistent stomach pain that spreads to the back, with or without vomiting, should be assessed urgently, as this may indicate a rare but serious reaction. The MHRA's Yellow Card scheme allows patients to report any suspected side effects directly to the regulator, which actively shapes safety guidance for medicines like Wegovy.

For a broader overview of how semaglutide works and what the treatment involves, the semaglutide treatment page covers the mechanism, the dose schedule, and eligibility in more detail. If you are weighing up the practical side of things (including what private treatment costs and what is included) an honest look at Wegovy pricing in the UK sets out what to expect. And if you have questions about the treatment as a whole, our Wegovy overview is a good starting point before deciding whether to go ahead.

Once a prescriber confirms suitability, the process at nume is straightforward. Consultations are reviewed the same day by a GPhC-registered Independent Prescriber. Your pen arrives via DPD the next working day, tracked, in plain unbranded packaging, nothing on the outside to suggest what is inside. That part is simple. The clinical assessment before it is what makes it safe.

If you are ready to find out whether Wegovy is right for you, start your free consultation and our prescribers will review your information the same day.